title: National glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health - August 2004.
authors.affiliation: Clinical Microbiology and Public Health Laboratory, Health Protection Agency, Addenbrooke's Hospital, Cambridge CB2 2QW, UK. dfjb2@cam.ac.uk
authors.forename: D F J
authors.initials: DF
authors.lastname: Brown
authors.forename: N M
authors.initials: NM
authors.lastname: Brown
authors.forename: B D
authors.initials: BD
authors.lastname: Cookson
authors.forename: G
authors.initials: G
authors.lastname: Duckworth
authors.forename: M
authors.initials: M
authors.lastname: Farrington
authors.forename: G L
authors.initials: GL
authors.lastname: French
authors.forename: L
authors.initials: L
authors.lastname: King
authors.forename: D
authors.initials: D
authors.lastname: Lewis
authors.forename: D M
authors.initials: DM
authors.lastname: Livermore
authors.forename: B
authors.initials: B
authors.lastname: Macrae
authors.forename: G M
authors.initials: GM
authors.lastname: Scott
authors.forename: D
authors.initials: D
authors.lastname: Williams
authors.forename: N
authors.initials: N
authors.lastname: Woodford
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D016983:Enterococcus / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D006020:Glycopeptides / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007755:Laboratories, Hospital; D011159:Population Surveillance / Q000379:methods*; D012307:Risk Factors; D011795:Surveys and Questionnaires; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides